Urinary Bladder Cancer Risk Factors: A Lebanese Case-Control Study
Bladder cancer is the second most incident malignancy among Lebanese men. The purpose of this study was to investigate potential risk factors associated with this observed high incidence. A case-control study (54 cases and 105 hospital-based controls) was conducted in two major hospitals in Beirut....
Uložené v:
| Vydané v: | Asian Pacific journal of cancer prevention : APJCP Ročník 14; číslo 5; s. 3205 - 3211 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Thailand
01.01.2013
|
| Predmet: | |
| ISSN: | 1513-7368, 2476-762X, 2476-762X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Bladder cancer is the second most incident malignancy among Lebanese men. The purpose of this study was to investigate potential risk factors associated with this observed high incidence.
A case-control study (54 cases and 105 hospital-based controls) was conducted in two major hospitals in Beirut. Cases were randomly selected from patients diagnosed in the period of 2002-2008. Controls were conveniently selected from the same settings. Data were collected using interview questionnaire and blood analysis. Exposure data were collected using a structured face-to-face interview questionnaire. Blood samples were collected to determine N-acetyltransferase1 (NAT1) genotype by PCR-RFLP. Analyses revolved around univariate, bivariate and multivariate logistic regression, along with checks for effect modification.
The odds of having bladder cancer among smokers was 1.02 times significantly higher in cases vs. controls. The odds of exposure to occupational diesel or fuel combustion fumes were 4.1 times significantly higher in cases vs controls. The odds of prostate-related morbidity were 5.6 times significantly higher in cases vs controls. Cases and controls showed different clustering patterns of NAT1 alleles. No significant differences between cases and controls were found for consumption of alcohol, coffee, tea, or artificial sweeteners.
This is the first case-control study investigating bladder cancer risk factors in the Lebanese context. Results confirmed established risk factors in the literature, particularly smoking and occupational exposure to diesel. The herein observed associations should be used to develop appropriate prevention policies and intervention strategies, in order to control this alarming disease in Lebanon. |
|---|---|
| AbstractList | Bladder cancer is the second most incident malignancy among Lebanese men. The purpose of this study was to investigate potential risk factors associated with this observed high incidence.
A case-control study (54 cases and 105 hospital-based controls) was conducted in two major hospitals in Beirut. Cases were randomly selected from patients diagnosed in the period of 2002-2008. Controls were conveniently selected from the same settings. Data were collected using interview questionnaire and blood analysis. Exposure data were collected using a structured face-to-face interview questionnaire. Blood samples were collected to determine N-acetyltransferase1 (NAT1) genotype by PCR-RFLP. Analyses revolved around univariate, bivariate and multivariate logistic regression, along with checks for effect modification.
The odds of having bladder cancer among smokers was 1.02 times significantly higher in cases vs. controls. The odds of exposure to occupational diesel or fuel combustion fumes were 4.1 times significantly higher in cases vs controls. The odds of prostate-related morbidity were 5.6 times significantly higher in cases vs controls. Cases and controls showed different clustering patterns of NAT1 alleles. No significant differences between cases and controls were found for consumption of alcohol, coffee, tea, or artificial sweeteners.
This is the first case-control study investigating bladder cancer risk factors in the Lebanese context. Results confirmed established risk factors in the literature, particularly smoking and occupational exposure to diesel. The herein observed associations should be used to develop appropriate prevention policies and intervention strategies, in order to control this alarming disease in Lebanon. Bladder cancer is the second most incident malignancy among Lebanese men. The purpose of this study was to investigate potential risk factors associated with this observed high incidence.BACKGROUNDBladder cancer is the second most incident malignancy among Lebanese men. The purpose of this study was to investigate potential risk factors associated with this observed high incidence.A case-control study (54 cases and 105 hospital-based controls) was conducted in two major hospitals in Beirut. Cases were randomly selected from patients diagnosed in the period of 2002-2008. Controls were conveniently selected from the same settings. Data were collected using interview questionnaire and blood analysis. Exposure data were collected using a structured face-to-face interview questionnaire. Blood samples were collected to determine N-acetyltransferase1 (NAT1) genotype by PCR-RFLP. Analyses revolved around univariate, bivariate and multivariate logistic regression, along with checks for effect modification.METHODSA case-control study (54 cases and 105 hospital-based controls) was conducted in two major hospitals in Beirut. Cases were randomly selected from patients diagnosed in the period of 2002-2008. Controls were conveniently selected from the same settings. Data were collected using interview questionnaire and blood analysis. Exposure data were collected using a structured face-to-face interview questionnaire. Blood samples were collected to determine N-acetyltransferase1 (NAT1) genotype by PCR-RFLP. Analyses revolved around univariate, bivariate and multivariate logistic regression, along with checks for effect modification.The odds of having bladder cancer among smokers was 1.02 times significantly higher in cases vs. controls. The odds of exposure to occupational diesel or fuel combustion fumes were 4.1 times significantly higher in cases vs controls. The odds of prostate-related morbidity were 5.6 times significantly higher in cases vs controls. Cases and controls showed different clustering patterns of NAT1 alleles. No significant differences between cases and controls were found for consumption of alcohol, coffee, tea, or artificial sweeteners.RESULTSThe odds of having bladder cancer among smokers was 1.02 times significantly higher in cases vs. controls. The odds of exposure to occupational diesel or fuel combustion fumes were 4.1 times significantly higher in cases vs controls. The odds of prostate-related morbidity were 5.6 times significantly higher in cases vs controls. Cases and controls showed different clustering patterns of NAT1 alleles. No significant differences between cases and controls were found for consumption of alcohol, coffee, tea, or artificial sweeteners.This is the first case-control study investigating bladder cancer risk factors in the Lebanese context. Results confirmed established risk factors in the literature, particularly smoking and occupational exposure to diesel. The herein observed associations should be used to develop appropriate prevention policies and intervention strategies, in order to control this alarming disease in Lebanon.CONCLUSIONSThis is the first case-control study investigating bladder cancer risk factors in the Lebanese context. Results confirmed established risk factors in the literature, particularly smoking and occupational exposure to diesel. The herein observed associations should be used to develop appropriate prevention policies and intervention strategies, in order to control this alarming disease in Lebanon. |
| Author | Moussa, Mohamad Ahmad Dhaini, Hassan Rida Kobeissi, Loulou Hassan Yassine, Ibrahim Adnan Jabbour, Michel Elias |
| Author_xml | – sequence: 1 givenname: Loulou Hassan surname: Kobeissi fullname: Kobeissi, Loulou Hassan – sequence: 2 givenname: Ibrahim Adnan surname: Yassine fullname: Yassine, Ibrahim Adnan – sequence: 3 givenname: Michel Elias surname: Jabbour fullname: Jabbour, Michel Elias – sequence: 4 givenname: Mohamad Ahmad surname: Moussa fullname: Moussa, Mohamad Ahmad – sequence: 5 givenname: Hassan Rida surname: Dhaini fullname: Dhaini, Hassan Rida |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23803105$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kElPwzAQhS1URBf4BwjlyCXBS7y0tzaiLKpEBVTiZjmOLQXSpNjJof8eh7YXDpyeRvPeaN43BoO6qQ0A1wgmnKD0br5-ztYJhogkKE1oQjCkZ2CEU85izvDHAIwQRSTmhIkhGHv_CWFKBacXYIiJgARBOgKLjStr5fbRolJFYVyUqVoHeS39V7RUum2cn0XzaGVyVRtvwt6bOGvq1jVV9NZ2xf4SnFtVeXN11AnYLO_fs8d49fLwlM1XsSaUtDG3SAuBC4ygENZgoacEW4ZziwvElLCWKUttKozRthAiJxQZa7WBQRBSZAJuD3d3rvnujG_ltvTaVFV4rOm8RIRjNmWI8WC9OVq7fGsKuXPlNpSUp97BMDsYtGu8d8ZKXbaqLfteqqwkgrKHLH8hyx6yDBOVPeQQTv-ET_f_jf0ANAl_LA |
| CitedBy_id | crossref_primary_10_1080_10937404_2013_878679 crossref_primary_10_1002_mc_23232 crossref_primary_10_3892_ol_2015_3337 crossref_primary_10_1016_j_apr_2025_102571 crossref_primary_10_1016_j_yrtph_2023_105369 crossref_primary_10_1097_FPC_0000000000000062 crossref_primary_10_3892_mco_2015_550 crossref_primary_10_1038_s41397_024_00336_z crossref_primary_10_7314_APJCP_2013_14_9_5107 crossref_primary_10_3390_jcm12041314 crossref_primary_10_1177_1073274818789359 crossref_primary_10_1155_2021_6615832 crossref_primary_10_1186_s12885_017_3304_7 crossref_primary_10_1371_journal_pone_0178527 crossref_primary_10_1016_j_gene_2024_148252 crossref_primary_10_1097_MD_0000000000037492 crossref_primary_10_5301_jbm_5000164 |
| Cites_doi | 10.1128/CMR.12.1.97 10.1097/00008571-199802000-00009 10.1111/j.1442-2042.2004.00740.x 10.1093/carcin/24.3.483 10.1002/ajim.4700030204 10.1006/abio.1997.2379 10.1016/j.canlet.2005.12.025 10.1158/1055-9965.EPI-06-0021 10.1002/(SICI)1097-0274(199811)34:5<506::AID-AJIM12>3.0.CO;2-5 10.1097/00008571-200006000-00002 10.1097/00008571-199802000-00008 10.1136/oem.58.9.590 10.1007/s10552-011-9788-6 10.1007/BF00155549 10.1093/ije/23.6.1145 10.1097/01.jom.0000169094.77036.1d 10.1007/BF00115641 10.1016/j.annepidem.2003.12.002 10.1097/01.smj.0000247266.10393.72 10.1023/B:CACO.0000007962.19066.9c 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M 10.1177/030089160709300102 10.3322/caac.20107 10.1158/1055-9965.EPI-11-0589 10.1097/00008571-200002000-00010 10.1007/s00345-009-0383-3 10.1002/ijc.25516 10.1046/j.1523-5394.2002.106011.x 10.1080/02652039309374156 10.1097/00008469-200102000-00002 10.1007/s00345-003-0382-8 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.7314/APJCP.2013.14.5.3205 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2476-762X |
| EndPage | 3211 |
| ExternalDocumentID | 23803105 10_7314_APJCP_2013_14_5_3205 |
| Genre | Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- .UV 23N 2WC 53G 5GY 9ZL AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV CITATION E3Z EBS EJD F5P FRJ GROUPED_DOAJ GX1 JDI OK1 OVT RPM TR2 W2D WOW CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c353t-7f1c882d21088fe28c932f62bf2d16a8ff6af5f48eecfd88b351effce01ef11a3 |
| ISICitedReferencesCount | 36 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000331473400090&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1513-7368 2476-762X |
| IngestDate | Thu Jul 10 22:27:24 EDT 2025 Sat Sep 18 02:45:51 EDT 2021 Tue Nov 18 21:32:43 EST 2025 Sat Nov 29 06:43:11 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c353t-7f1c882d21088fe28c932f62bf2d16a8ff6af5f48eecfd88b351effce01ef11a3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | http://society.kisti.re.kr/sv/SV_svpsbs03V.do?method=download&cn1=JAKO201321251181908 |
| PMID | 23803105 |
| PQID | 1372696167 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_1372696167 pubmed_primary_23803105 crossref_citationtrail_10_7314_APJCP_2013_14_5_3205 crossref_primary_10_7314_APJCP_2013_14_5_3205 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-01-01 |
| PublicationDateYYYYMMDD | 2013-01-01 |
| PublicationDate_xml | – month: 01 year: 2013 text: 2013-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Thailand |
| PublicationPlace_xml | – name: Thailand |
| PublicationTitle | Asian Pacific journal of cancer prevention : APJCP |
| PublicationTitleAlternate | Asian Pac J Cancer Prev |
| PublicationYear | 2013 |
| References | (POCPA9_2013_v14n5_3205_015) 2007; 93 (POCPA9_2013_v14n5_3205_025) 2006; 99 (POCPA9_2013_v14n5_3205_002) 2005; 47 (POCPA9_2013_v14n5_3205_040) 2004; 21 (POCPA9_2013_v14n5_3205_022) 1999; 12 (POCPA9_2013_v14n5_3205_042) 2012; 21 (POCPA9_2013_v14n5_3205_008) 2010; 127 (POCPA9_2013_v14n5_3205_013) 1998; 8 (POCPA9_2013_v14n5_3205_007) 2000; 10 (POCPA9_2013_v14n5_3205_026) 2002; 10 (POCPA9_2013_v14n5_3205_028) 1993; 10 (POCPA9_2013_v14n5_3205_031) 1984; 72 (POCPA9_2013_v14n5_3205_036) 2011; 22 (POCPA9_2013_v14n5_3205_027) 2009; 27 (POCPA9_2013_v14n5_3205_014) 1990; 6 (POCPA9_2013_v14n5_3205_030) 2006; 15 (POCPA9_2013_v14n5_3205_020) 1996; 7 (POCPA9_2013_v14n5_3205_034) 2001; 10 (POCPA9_2013_v14n5_3205_039) 2012; 2012 (POCPA9_2013_v14n5_3205_003) 2000; 86 (POCPA9_2013_v14n5_3205_010) 2000; 9 (POCPA9_2013_v14n5_3205_006) 1997; 253 (POCPA9_2013_v14n5_3205_024) 2001; 10 (POCPA9_2013_v14n5_3205_032) 2010; 1 (POCPA9_2013_v14n5_3205_033) 2004; 14 (POCPA9_2013_v14n5_3205_009) 2003; 24 (POCPA9_2013_v14n5_3205_004) 1998; 8 (POCPA9_2013_v14n5_3205_041) 2001; 58 (POCPA9_2013_v14n5_3205_005) 1994; 23 (POCPA9_2013_v14n5_3205_011) 2000; 10 (POCPA9_2013_v14n5_3205_018) 2003; 14 (POCPA9_2013_v14n5_3205_038) 1982; 3 (POCPA9_2013_v14n5_3205_012) 1980; 1 (POCPA9_2013_v14n5_3205_035) 2004; 11 (POCPA9_2013_v14n5_3205_016) 2011; 61 (POCPA9_2013_v14n5_3205_023) 2011; 14 (POCPA9_2013_v14n5_3205_017) 2007; 245 (POCPA9_2013_v14n5_3205_001) 1998; 34 (POCPA9_2013_v14n5_3205_029) 2008; 16 |
| References_xml | – volume: 12 start-page: 97 year: 1999 ident: POCPA9_2013_v14n5_3205_022 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.12.1.97 – volume: 8 start-page: 67 year: 1998 ident: POCPA9_2013_v14n5_3205_004 publication-title: Pharmacogenetics doi: 10.1097/00008571-199802000-00009 – volume: 11 start-page: 11 year: 2004 ident: POCPA9_2013_v14n5_3205_035 publication-title: Int J Urol doi: 10.1111/j.1442-2042.2004.00740.x – volume: 24 start-page: 483 year: 2003 ident: POCPA9_2013_v14n5_3205_009 publication-title: Carcinogenesis doi: 10.1093/carcin/24.3.483 – volume: 3 start-page: 139 year: 1982 ident: POCPA9_2013_v14n5_3205_038 publication-title: Am J Ind Med doi: 10.1002/ajim.4700030204 – volume: 253 start-page: 219 year: 1997 ident: POCPA9_2013_v14n5_3205_006 publication-title: Anal Biochem doi: 10.1006/abio.1997.2379 – volume: 1 start-page: 837 year: 1980 ident: POCPA9_2013_v14n5_3205_012 publication-title: Lancet – volume: 245 start-page: 51 year: 2007 ident: POCPA9_2013_v14n5_3205_017 publication-title: Cancer Lett doi: 10.1016/j.canlet.2005.12.025 – volume: 72 start-page: 973 year: 1984 ident: POCPA9_2013_v14n5_3205_031 publication-title: J Natl Cancer Inst – volume: 15 start-page: 1348 year: 2006 ident: POCPA9_2013_v14n5_3205_030 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-06-0021 – volume: 34 start-page: 506 year: 1998 ident: POCPA9_2013_v14n5_3205_001 publication-title: Am J Ind Med doi: 10.1002/(SICI)1097-0274(199811)34:5<506::AID-AJIM12>3.0.CO;2-5 – volume: 10 start-page: 291 year: 2000 ident: POCPA9_2013_v14n5_3205_011 publication-title: Pharmacogenetics doi: 10.1097/00008571-200006000-00002 – volume: 8 start-page: 55 year: 1998 ident: POCPA9_2013_v14n5_3205_013 publication-title: Pharmacogenetics doi: 10.1097/00008571-199802000-00008 – volume: 58 start-page: 590 year: 2001 ident: POCPA9_2013_v14n5_3205_041 publication-title: Occup Environ Med doi: 10.1136/oem.58.9.590 – volume: 22 start-page: 1205 year: 2011 ident: POCPA9_2013_v14n5_3205_036 publication-title: Cancer Causes Control doi: 10.1007/s10552-011-9788-6 – volume: 6 start-page: 49 year: 1990 ident: POCPA9_2013_v14n5_3205_014 publication-title: Eur J Epidemiol doi: 10.1007/BF00155549 – volume: 23 start-page: 1145 year: 1994 ident: POCPA9_2013_v14n5_3205_005 publication-title: Int J Epidemiol doi: 10.1093/ije/23.6.1145 – volume: 1 start-page: 41 year: 2010 ident: POCPA9_2013_v14n5_3205_032 publication-title: Middle East J Cancer – volume: 2012 start-page: 512976 year: 2012 ident: POCPA9_2013_v14n5_3205_039 publication-title: J Oncol, – volume: 47 start-page: 854 year: 2005 ident: POCPA9_2013_v14n5_3205_002 publication-title: J Occup Environ Med doi: 10.1097/01.jom.0000169094.77036.1d – volume: 7 start-page: 95 year: 1996 ident: POCPA9_2013_v14n5_3205_020 publication-title: Cancer Causes Control doi: 10.1007/BF00115641 – volume: 14 start-page: 663 year: 2004 ident: POCPA9_2013_v14n5_3205_033 publication-title: Ann Epidemiol doi: 10.1016/j.annepidem.2003.12.002 – volume: 99 start-page: 1256 year: 2006 ident: POCPA9_2013_v14n5_3205_025 publication-title: South Med J doi: 10.1097/01.smj.0000247266.10393.72 – volume: 16 start-page: 1280 year: 2008 ident: POCPA9_2013_v14n5_3205_029 publication-title: East Mediterr Hlth J – volume: 14 start-page: 907 year: 2003 ident: POCPA9_2013_v14n5_3205_018 publication-title: Cancer Causes Control doi: 10.1023/B:CACO.0000007962.19066.9c – volume: 86 start-page: 289 year: 2000 ident: POCPA9_2013_v14n5_3205_003 publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M – volume: 10 start-page: 1249 year: 2001 ident: POCPA9_2013_v14n5_3205_034 publication-title: Cancer Epidemiol Biomarkers Prev – volume: 93 start-page: 4 year: 2007 ident: POCPA9_2013_v14n5_3205_015 publication-title: Tumori doi: 10.1177/030089160709300102 – volume: 14 start-page: 315 year: 2011 ident: POCPA9_2013_v14n5_3205_023 publication-title: Biomed Central Public Hlth, – volume: 61 start-page: 69 year: 2011 ident: POCPA9_2013_v14n5_3205_016 publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 – volume: 21 start-page: 537 year: 2012 ident: POCPA9_2013_v14n5_3205_042 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-11-0589 – volume: 10 start-page: 79 year: 2000 ident: POCPA9_2013_v14n5_3205_007 publication-title: Pharmacogenetics doi: 10.1097/00008571-200002000-00010 – volume: 9 start-page: 29 year: 2000 ident: POCPA9_2013_v14n5_3205_010 publication-title: Cancer Epidemiol Biomarkers Prev – volume: 27 start-page: 289 year: 2009 ident: POCPA9_2013_v14n5_3205_027 publication-title: World J Urol doi: 10.1007/s00345-009-0383-3 – volume: 127 start-page: 2893 year: 2010 ident: POCPA9_2013_v14n5_3205_008 publication-title: Int J Cancer doi: 10.1002/ijc.25516 – volume: 10 start-page: 311 year: 2002 ident: POCPA9_2013_v14n5_3205_026 publication-title: Cancer Pract doi: 10.1046/j.1523-5394.2002.106011.x – volume: 10 start-page: 337 year: 1993 ident: POCPA9_2013_v14n5_3205_028 publication-title: Food Addit Contam, doi: 10.1080/02652039309374156 – volume: 10 start-page: 7 year: 2001 ident: POCPA9_2013_v14n5_3205_024 publication-title: Eur J Cancer Prev doi: 10.1097/00008469-200102000-00002 – volume: 21 start-page: 392 year: 2004 ident: POCPA9_2013_v14n5_3205_040 publication-title: World J Urol doi: 10.1007/s00345-003-0382-8 |
| SSID | ssj0045875 |
| Score | 2.1646538 |
| Snippet | Bladder cancer is the second most incident malignancy among Lebanese men. The purpose of this study was to investigate potential risk factors associated with... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database Enrichment Source |
| StartPage | 3205 |
| SubjectTerms | Aged Arylamine N-Acetyltransferase - genetics Case-Control Studies Coffee Female Follow-Up Studies Genotype Humans Isoenzymes - genetics Male Occupational Exposure - adverse effects Polymerase Chain Reaction Polymorphism, Genetic - genetics Polymorphism, Restriction Fragment Length Prognosis Risk Factors Smoking - adverse effects Tea Urinary Bladder Neoplasms - etiology |
| Title | Urinary Bladder Cancer Risk Factors: A Lebanese Case-Control Study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23803105 https://www.proquest.com/docview/1372696167 |
| Volume | 14 |
| WOSCitedRecordID | wos000331473400090&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2476-762X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0045875 issn: 1513-7368 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6gRAviOsolylIvFUZsx0nDm9dxTQGrSrYpPIUOY6tVuqSKmun_Tf-HOfESRombnvgxW2d5LTx-XIu7rkQ8lZGitlQCZ9Jzf1Ags-qjEh9OF-FaYwq1DWbiCYTOZvF017ve5MLc7WM8lxeX8er_8pqmANmY-rsLdjdEoUJeA9MhxHYDuM_Mf68dCm2R0sUKuVghHwtB18whvzYdddx6eifTaqw_ySccWn8UR2z_rWtN9vUpq3SLOvgvW6lCe0Ir-oiUAgjpDs9HbU5Y5-K1ABnXQZ2sVkWm8EJWOtbRH6DTwu3qfoR_Pb54mIwzPLt8VPsdbYpmwB_s8Q4NNX6AeNiA9Sqo8VcXahsMJzD2N3KwLYS7VZGLX1hLuKuz04rnoMODEVH1nJ2KDp6mzMntW_qhIjTAGtT4N1jKB8H5XAgDrZXd0tw31CNbcAiuEpIJ6moJEgFfKZEJEhlh9xhkYjjxp93ZkAgZFXlub0nl7eJVN796rf8bBf9xtmpjJ6zh-RB7a14Q4eyR6Rn8sfk3riOx3hCjmqweTXYPAc2D8Hm1WB77w29BmpeF2peBbWn5Pz4w9noxK-7cviaC772I0s1uGUZo6CgrIFnHFwAG7LUsoyGSlp49K2wgTRG20zKlAtqrNXmEF4oVfwZ2c2L3DwnnrZMmiCVXPM4ONRGUbDYNAtkxjQzNO0T3qxJouuS9dg5ZZn8iR994rdXrVzJlr-c_6ZZ7gRkK_5hBksC-E0oj1gYhzSM-mTP8aGlCKYuVtUVL275bS_J_S30X5Hddbkxr8ldfbVeXJb7ZCeayf0KSDBOpuMf_Suhdg |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Urinary+Bladder+Cancer+Risk+Factors%3A+A+Lebanese+Case-Control+Study&rft.jtitle=Asian+Pacific+journal+of+cancer+prevention+%3A+APJCP&rft.au=Kobeissi%2C+Loulou+Hassan&rft.au=Yassine%2C+Ibrahim+Adnan&rft.au=Jabbour%2C+Michel+Elias&rft.au=Moussa%2C+Mohamad+Ahmad&rft.date=2013-01-01&rft.issn=1513-7368&rft.volume=14&rft.issue=5&rft.spage=3205&rft.epage=3211&rft_id=info:doi/10.7314%2FAPJCP.2013.14.5.3205&rft.externalDBID=n%2Fa&rft.externalDocID=10_7314_APJCP_2013_14_5_3205 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1513-7368&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1513-7368&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1513-7368&client=summon |